| Net Cash Provided by (Used in) Operating Activities |
-10K |
USD |
-110% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
21.1K |
USD |
|
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.08M |
USD |
-4.29% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
469K |
USD |
+8.25% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
469K |
USD |
+8.25% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
-35.7K |
USD |
+10% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
460K |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1.03M |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
4.45K |
USD |
|
Q4 2024 |
FY 2024 |
| Current Federal Tax Expense (Benefit) |
12.5K |
USD |
-42.9% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |